+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cells Market - Global Forecast 2026-2032- Product Image
Stem Cells Market - Global Forecast 2026-2032- Product Image
New

Stem Cells Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082652
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Stem cell technologies are redefining the way organizations advance therapeutic research, develop novel drug solutions, and reinforce healthcare supply chains. For senior decision-makers, these innovations signal opportunities for growth, operational resilience, and strategic differentiation in a dynamic market.

Market Snapshot: Stem Cells Market Overview

The global stem cells market is experiencing robust growth, with projections indicating expansion through 2032. This momentum is underpinned by scientific advancements in regenerative medicine, enhanced capabilities in drug discovery, and personalized healthcare approaches. Collaboration among biopharmaceutical companies, research institutes, and contract partners accelerates the delivery of new solutions to the market. Stakeholders benefit from a landscape where research excellence and commercial opportunity align, strengthening long-term prospects for both established and emerging organizations.

Scope & Segmentation

  • Cell Types: Includes adult stem cells, human embryonic stem cells, and induced pluripotent stem cells, each shaping research direction and therapy development.
  • Sourcing Models: Both allogeneic and autologous approaches influence research and development strategy, regulatory compliance, manufacturing methods, and patient accessibility.
  • Tissue Origins: Adipose tissue, bone marrow, peripheral blood, amniotic fluid, and umbilical cord are central to diversified research pipelines and therapy design.
  • Technologies: Innovations such as bioprinting, advanced two- and three-dimensional culture systems, and gene editing platforms (including CRISPR and TALENs) support predictive modeling and enhance preclinical and clinical study outcomes.
  • Applications: The market encompasses banking of cells in private and public settings, pharmaceutical screening, toxicity testing, regenerative interventions for cardiovascular, neurological, and orthopedic conditions, plus discovery research and translational projects.
  • End Users: Organizations utilizing these technologies include biopharmaceutical firms, contract research organizations, hospitals, clinics, and specialized research institutes.
  • Geographies: The Americas, Europe, Middle East and Africa, and Asia Pacific regions each contribute unique drivers—from regulatory climates to investment trends and research partnerships—shaping global competitiveness.

Key Takeaways: Stem Cell Technologies

  • Regenerative therapies and next-generation drug pipelines increasingly rely on stem cell innovation, offering measurable opportunities for product differentiation and streamlined market entry.
  • Cutting-edge bioprinting and 3D culture techniques deliver greater accuracy in preclinical investigations, boosting the efficiency of pharmaceutical screening and safety validation.
  • Incorporation of gene editing tools, such as CRISPR, has improved the precision and scalability of stem cell engineering for tailored healthcare solutions.
  • Strategic collaborations among hospitals, academic institutes, and commercial entities promote resource optimization, quality harmonization, and efficient translation of research findings into clinical applications.
  • Dual approaches in tissue sourcing and investment in private and public cell banking bolster supply chain resilience and facilitate growth in personalized medicine programs.
  • Adaptation to evolving regulatory trends is essential, with organizations leveraging streamlined clinical pathways and establishing regional partnerships to sustain competitiveness.

Tariff Impact

Recent adjustments to US tariff policies are reshaping supply chain strategies in the stem cells market. Access to critical reagents, bioreactors, and gene editing kits is being affected, prompting organizations to diversify suppliers and develop local manufacturing partnerships. This adaptation enhances logistics reliability, encourages domestic technology transfer, and drives investment in onsite production capabilities that can mitigate rising costs and delivery delays.

Methodology & Data Sources

Market analysis combined extensive interviews with senior executives, scientific experts, and regulatory advisors, with comprehensive secondary reviews of industry publications and government documents. Data triangulation and advanced analytics underpin the reliable insights and evaluation of market dynamics and regulatory changes in this report.

Why This Report Matters

  • Offers a clear perspective on the strategic landscape, helping leaders pinpoint actionable opportunities for organizational growth within the stem cells market.
  • Clarifies how segment trends, technical advances, and policy shifts intersect to shape investment priorities and influence operational risks.
  • Supports the creation of resilient supply chain strategies and encourages greater cross-sector collaboration throughout the life sciences value chain.

Conclusion

The evolving stem cells sector requires balancing technology integration, supply chain strengths, and collaborative efforts. Leadership in this arena rests on the ability to align innovation capacity with shifting regulatory and regional imperatives for sustained market relevance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Stem Cells Market, by Cell Type
8.1. Adult Stem Cells
8.2. Human Embryonic Stem Cells
8.3. Induced Pluripotent Stem Cells
9. Stem Cells Market, by Cell Source
9.1. Allogeneic
9.2. Autologous
10. Stem Cells Market, by Technology
10.1. Bioprinting
10.2. Cell Culture
10.2.1. 2D Culture
10.2.2. 3D Culture
10.3. Gene Editing
10.3.1. CRISPR
10.3.2. Transcription Activator-Like Effector Nuclease
11. Stem Cells Market, by Cell Source
11.1. Adipose Tissue
11.2. Amniotic Cells
11.3. Bone Marrow
11.4. Peripheral Blood
11.5. Umbilical Cord
12. Stem Cells Market, by Application
12.1. Cell Banking
12.1.1. Private Banking
12.1.2. Public Banking
12.2. Drug Discovery & Testing
12.2.1. Pharmaceutical Screening
12.2.2. Toxicity Testing
12.3. Regenerative Medicine
12.3.1. Cardiovascular
12.3.2. Neurology
12.3.3. Orthopaedics
12.4. Research & Development
13. Stem Cells Market, by End User
13.1. Biopharmaceutical Companies
13.2. Contract Research Organizations
13.3. Hospitals & Clinics
13.4. Research Institutes
14. Stem Cells Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Stem Cells Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Stem Cells Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Stem Cells Market
18. China Stem Cells Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Advanced Cell Technology, Inc.
19.6. AlloSource, Inc.
19.7. Anterogen Co., Ltd.
19.8. Athersys Inc.
19.9. Becton, Dickinson and Company
19.10. Bioheart Inc.
19.11. Biorestorative Therapies Inc.
19.12. BrainStorm Cell Therapeutics Inc.
19.13. Bristol-Myers Squibb Company
19.14. Cellartis AB
19.15. Cellular Engineering Technologies Inc.
19.16. Charles River Laboratories International, Inc.
19.17. Danaher Corporation
19.18. Gamida Cell Ltd
19.19. GE HealthCare by General Electric Company
19.20. GenScript Biotech Corporation
19.21. Gilead Sciences, Inc.
19.22. HOLOSTEM S.r.l. by Chiesi Farmaceutici S.p.A
19.23. JCR Pharmaceuticals Co., Ltd.
19.24. Lineage Cell Therapeutics, Inc.
19.25. Lonza Group
19.26. Merck KGaA
19.27. Novartis AG
19.28. Novo Holdings A/S
19.29. NuVasive Inc.
19.30. Pluristyx, Inc.
19.31. Sartorius AG
19.32. STEMCELL Group of Companies
19.33. Takeda Pharmaceutical Company Limited
19.34. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY BIOPRINTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY BIOPRINTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY BIOPRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL STEM CELLS MARKET SIZE, BY 2D CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL STEM CELLS MARKET SIZE, BY 2D CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL STEM CELLS MARKET SIZE, BY 2D CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL STEM CELLS MARKET SIZE, BY 3D CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL STEM CELLS MARKET SIZE, BY 3D CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL STEM CELLS MARKET SIZE, BY 3D CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL STEM CELLS MARKET SIZE, BY CRISPR, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL STEM CELLS MARKET SIZE, BY CRISPR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL STEM CELLS MARKET SIZE, BY CRISPR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL STEM CELLS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL STEM CELLS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL STEM CELLS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL STEM CELLS MARKET SIZE, BY AMNIOTIC CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL STEM CELLS MARKET SIZE, BY AMNIOTIC CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL STEM CELLS MARKET SIZE, BY AMNIOTIC CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL STEM CELLS MARKET SIZE, BY PRIVATE BANKING, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL STEM CELLS MARKET SIZE, BY PRIVATE BANKING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL STEM CELLS MARKET SIZE, BY PRIVATE BANKING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL STEM CELLS MARKET SIZE, BY PUBLIC BANKING, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL STEM CELLS MARKET SIZE, BY PUBLIC BANKING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL STEM CELLS MARKET SIZE, BY PUBLIC BANKING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL STEM CELLS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL STEM CELLS MARKET SIZE, BY TOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL STEM CELLS MARKET SIZE, BY TOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL STEM CELLS MARKET SIZE, BY ORTHOPAEDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL STEM CELLS MARKET SIZE, BY ORTHOPAEDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL STEM CELLS MARKET SIZE, BY ORTHOPAEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS STEM CELLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. EUROPE STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 164. EUROPE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 167. EUROPE STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 168. EUROPE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 185. AFRICA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. AFRICA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 187. AFRICA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 188. AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 189. AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. AFRICA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 191. AFRICA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 192. AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 193. AFRICA STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL STEM CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. ASEAN STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 209. ASEAN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 210. ASEAN STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 211. ASEAN STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 212. ASEAN STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 213. ASEAN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 214. ASEAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. ASEAN STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 216. ASEAN STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 217. ASEAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. GCC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. GCC STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 221. GCC STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 222. GCC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. GCC STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 224. GCC STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 225. GCC STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 226. GCC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. GCC STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 228. GCC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 229. GCC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 230. GCC STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. BRICS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. BRICS STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 245. BRICS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 246. BRICS STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 247. BRICS STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 248. BRICS STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 249. BRICS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 250. BRICS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. BRICS STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 252. BRICS STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 253. BRICS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 254. BRICS STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. G7 STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. G7 STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 257. G7 STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 258. G7 STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. G7 STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 260. G7 STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 261. G7 STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 262. G7 STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. G7 STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 264. G7 STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 265. G7 STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 266. G7 STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. NATO STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. NATO STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 269. NATO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 270. NATO STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 271. NATO STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 272. NATO STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 273. NATO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 274. NATO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 275. NATO STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 276. NATO STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 277. NATO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 278. NATO STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. CHINA STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. CHINA STEM CELLS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
TABLE 294. CHINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 295. CHINA STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 296. CHINA STEM CELLS MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 297. CHINA STEM CELLS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 298. CHINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 299. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. CHINA STEM CELLS MARKET SIZE, BY CELL BANKING, 2018-2032 (USD MILLION)
TABLE 301. CHINA STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & TESTING, 2018-2032 (USD MILLION)
TABLE 302. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
TABLE 303. CHINA STEM CELLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Stem Cells market report include:
  • Advanced Cell Technology, Inc.
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • Athersys Inc.
  • Becton, Dickinson and Company
  • Bioheart Inc.
  • Biorestorative Therapies Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Bristol-Myers Squibb Company
  • Cellartis AB
  • CellProthera SAS
  • Cellular Engineering Technologies Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Fate Therapeutics, Inc.
  • Gamida Cell Ltd
  • Gamida Cell Ltd.
  • Garuda Therapeutics
  • GE HealthCare by General Electric Company
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • HOLOSTEM S.r.l. by Chiesi Farmaceutici S.p.A
  • Holostem Terapie Avanzate S.r.l.
  • Jasper Therapeutics, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Juvena Therapeutics Inc.
  • Kangstem Biotech Co., Ltd.
  • Kite Pharma, Inc. by Gilead Sciences, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Lonza Group
  • Medeze Group
  • Merck KGaA
  • Mesoblast Ltd.
  • Novartis AG
  • Novo Holdings A/S
  • NuVasive Inc.
  • Plasticell
  • Pluristyx, Inc.
  • ReNeuron Group PLC
  • Sartorius AG
  • SQZ Biotechnologies Company by Stemcell Technologies
  • STEMCELL Group of Companies
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • U.S. Stem Cell Inc
  • Umoja Biopharma
  • Vericel Corporation

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 17.4 Billion
Forecasted Market Value ( USD ) by 2032 $ 33.18 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned50

Related Topics

Related Reports

Stem Cells - Global Strategic Business Report - Product Image

Stem Cells - Global Strategic Business Report

  • Report
  • 369 Pages
  • Global
From
Stem Cell Therapy Market - Global Forecast 2026-2032 - Product Image

Stem Cell Therapy Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025 - Product Image

Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025

  • Report
  • 389 Pages
  • Global
From
Technology Landscape, Trends and Opportunities in Stem Cell Therapy Market - Product Image

Technology Landscape, Trends and Opportunities in Stem Cell Therapy Market

  • Report
  • 150 Pages
  • Global
From
Human Embryonic Stem Cells Market - Global Forecast 2026-2032 - Product Image

Human Embryonic Stem Cells Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.